Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Showing posts with label neurotransmitters. Show all posts
Showing posts with label neurotransmitters. Show all posts

Thursday, October 12, 2017

Review: Could neurotransmitters influence neurogenesis and neurorepair after stroke?

I got absolutely nothing out of this. Useless. 
http://digital.csic.es/handle/10261/156126
Authors:

Sanchez-Mendoza, Eduardo; Bellver-Landete, V.; Merino, J.J.; González, M. P.; Martínez-Murillo, Ricardo ; Oset-Gasque, M.J.
Keywords: Glutamate
Neurotransmitters
Neurorepair
Neurogenesis
Neural progenitor cells (NPCs)
Brain ischaemia
Issue Date: 2013
Publisher: Blackwell Publishing
Citation: Neuropathology and Applied Neurobiology 39: 722- 735 (2013)
Abstract: Brain ischaemia and reperfusion produce alterations in the microenvironment of the parenchyma, including ATP depletion, ionic homeostasis alterations, inflammation, release of multiple cytokines and abnormal release of neurotransmitters. As a consequence, the induction of proliferation and migration of neural stem cells is redirected towards the peri-infarct region. The success of new neurorestorative treatments for damaged brain implies the need to describe with greater accuracy the mechanisms in charge of regulating adult neurogenesis, under both physiological and pathological conditions. Recent evidence demonstrates that many neurotransmitters, glutamate in particular, control the subventricular zone (SVZ), thus being part of the complex signal network that exerts a remarkable influence on the production of new neurones. Neurotransmitters provide a link between brain activity and SVZ neurogenesis. Therefore, a deeper knowledge of the role of neurotransmitters systems, such as glutamate and its transporters, in adult neurogenesis, may prove a valuable tool to be utilized as a neurorestorative therapy in this pathology. © 2013 British Neuropathological Society.
URI: http://hdl.handle.net/10261/156126
Identifiers: doi: 10.1111/nan.12082
issn: 0305-1846

Wednesday, August 23, 2017

Researchers Make Surprising Discovery About How Neurons Talk to Each Other

Your doctor should be able to translate this into a stroke rehab protocol to make our damaged connections work better.
https://www.technologynetworks.com/neuroscience/news/researchers-make-surprising-discovery-about-how-neurons-talk-to-each-other-291199
Researchers at the University of Pittsburgh have uncovered the mechanism by which neurons keep up with the demands of repeatedly sending signals to other neurons. The new findings, made in fruit flies and mice, challenge the existing dogma about how neurons that release the chemical signal dopamine communicate, and may have important implications for many dopamine-related diseases, including schizophrenia, Parkinson’s disease and addiction.

The research conducted at Pitt and Columbia University was published online today in the journal Neuron.

Neurons communicate with one another by releasing chemicals called neurotransmitters, such as dopamine and glutamate, into the small space between two neurons that is known as a synapse. Inside neurons, neurotransmitters awaiting release are housed in small sacs called synaptic vesicles.

“Our findings demonstrate, for the first time, that neurons can change how much dopamine they release as a function of their overall activity. When this mechanism doesn’t work properly, it could lead to profound effects on health,” explained the study’s senior author Zachary Freyberg, M.D., Ph.D., who recently joined Pitt as an assistant professor of psychiatry and cell biology. Freyberg initiated the research while at Columbia University.

When the researchers triggered the dopamine neurons to fire, the neurons’ vesicles began to release dopamine as expected. But then the team noticed something surprising: additional content was loaded into the vesicles before they had the opportunity to empty. Subsequent experiments showed that this activity-induced vesicle loading was due to an increase in acidity levels inside the vesicles.

“Our findings were completely unexpected,” said Freyberg. “They contradict the existing dogma that a finite amount of chemical signal is loaded into a vesicle at any given time, and that vesicle acidity is fixed.”

The team then demonstrated that the increase in acidity was driven by a transport channel in the cell’s surface, which allowed an influx of negatively charged glutamate ions to enter the neuron, thus increasing its acidity. Genetically removing the transporter in fruit flies and mice made the animals less responsive to amphetamine, a drug that exerts its effect by stimulating dopamine release from neurons.

“In this case, glutamate is not acting as a neurotransmitter. Instead it is functioning primarily as a source of negative charge, which is being used by these vesicles in a really clever way to manipulate vesicle acidity and therefore change their dopamine content,” Freyberg said. “This calls into question the whole textbook model of vesicles as having fixed amounts of single neurotransmitters. It appears that these vesicles contain both dopamine and glutamate, and dynamically modify their content to match the conditions of the cell as needed.”

In the future, the team plans to look more closely at how increases in vesicle acidification affect health. A number of brain diseases are characterized by abnormal dopamine neuron signaling and altered levels of the neurotransmitter.

“Since we have demonstrated that the balance between glutamate and dopamine is important for controlling the amount of dopamine that a neuron releases, it stands to reason that an imbalance between the two neurotransmitters could be contributing to symptoms in these diseases,” said Freyberg.

This article has been republished from materials provided by UPMC. Note: material may have been edited for length and content. For further information, please contact the cited source.

Sunday, July 30, 2017

CUMC researchers capture first snapshot of key brain receptor in action

Our researchers should be able to use this to  see what is wrong with these glutamate receptors post-stroke  and some up with solutions to glutamate poisoning in the neuronal cascade of death
http://www.news-medical.net/news/20170724/CUMC-researchers-capture-first-snapshot-of-key-brain-receptor-in-action.aspx
Columbia University Medical Center (CUMC) researchers have captured the first three-dimensional snapshots of the AMPA-subtype glutamate receptor in action. The receptor, which regulates most electrical signaling in the brain, is involved in several important brain activities, including memory and learning.
The findings were published today in Nature.
"With our new findings, we can now, for the first time, visualize how the neurotransmitter glutamate opens glutamate receptor ion channels," said Alexander Sobolevsky, PhD, associate professor of biochemistry and molecular biophysics at Columbia and senior author of the paper. "This is the fundamental process that directly affects learning and memory, and finding its structural determinants has been the primary goal of molecular neuroscience since the '90s."
Most signaling in the brain is triggered by glutamate, a neurotransmitter that activates proteins on the surface of neurons called glutamate receptors. Glutamate receptors underlie a variety of high cognitive functions, including learning and memory. AMPA receptors are glutamate receptors that open and close very quickly--in less than a millisecond--and are involved in fast processes in the brain, such as the rapid perception and reaction of an organism to its surrounding environment.
Previously, the Sobolevsky lab deciphered the structures of the AMPA receptor alone and in complex with other proteins that regulate the speed and strength of synaptic connections. In the current study, the researchers captured the AMPA receptor in action, as glutamate activates the receptor to allow ions to flow through its channel and initiate signaling in the brain. This provides the first precise insights into how receptors mediate brain function.
To freeze the AMPA receptor in an active state, the researchers fused it with stargazin, a regulatory protein that prompts the channel to open. The images they captured show that when signaling molecules such as glutamate are present, the entrance to the AMPA receptor, which consists of four units, opens up like a camera's iris, or aperture, to reveal its pore. To shepherd the ions through, the receptor widens the diameter of its channel, and a specialized channel pore lining ushers the ions into the cell.
"These new fundamental discoveries have implications for our understanding of neurotransmission by glutamate, our brain's major neurotransmitter" says Edward C. Twomey, a PhD candidate at CUMC and first author of the paper. "Understanding these processes will impact future studies on glutamate receptor signaling in neurodegenerative diseases as well as drug design."
To study the receptor, Sobolevksy's team used cryo-electron microscopy, a technique that captures an array of two-dimensional images of a molecule and combines them into a three-dimensional structural image. The method was pioneered by co-author Joachim Frank, PhD, professor of biochemistry and molecular biophysics and of biological sciences at CUMC.
Defects in glutamate receptors, or the processes they mediate, are implicated in neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis and glaucoma; psychiatric disorders such as anxiety, depression, schizophrenia, and drug use disorders; as well as in acute disorders such as brain trauma and stroke. The new structure of an active AMPA receptor and understanding of the activating mechanism create a solid platform for developing therapeutics to treat neurological disorders that are associated with glutamate receptor dysfunction.

Thursday, May 28, 2015

Microbes Effect on the Brain

This doctors' blog on this is too detailed to summarize so ask your doctor what is being done with this to adjust your stroke protocols for recovery. 

Microbes Effect on the Brain


A couple selected sentences;
Without microbes, there is a much higher level of stress steroids from the hypothalamus (corticosteroids) and a lower level of BDNF, (brain derived neurotrophic factor stimulates new neurons and brain connections).
Mice without microbes have decreases in several important neurotransmitters and factors. BDNF is lower, which affects the development of new brain cells for memory. 
Also, microbes make many other small molecules that can be neuro modulators or new neurotransmitters. This includes serotonin, dopamine, GABA, epinephrine, acetylcholine and others.
Mice without microbes have decreases in several important neurotransmitters and factors. BDNF is lower, which affects the development of new brain cells for memory. - See more at: http://jonlieffmd.com/blog/microbes-effect-on-the-brain#sthash.O7jw4XzD.dpuf


Without microbes, there is a much higher level of stress steroids from the hypothalamus (corticosteroids) and a lower level of BDNF, (brain derived neurotrophic factor stimulates new neurons and brain connections). - See more at: http://jonlieffmd.com/blog/microbes-effect-on-the-brain#sthash.O7jw4XzD.dpuf